For the quarter ending 2025-12-31, ESMC made $3,591,447 in revenue. $43,787 in net income. Net profit margin of 1.22%.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenues, net | 3,591,447 | 2,675,321 | 2,384,480* | - |
| Cost of product and service sold | 2,035,395 | 1,554,579 | 1,211,769* | - |
| Marketing, general and administrative | 1,326,132 | 1,107,395 | 1,232,624.5* | - |
| Research and development | 131,182 | 216,098 | 307,931.5* | - |
| Total costs and expenses | 3,492,709 | 2,878,072 | 2,752,325* | - |
| Income (gain) from operations | 98,738 | -202,751 | -367,845* | - |
| Other nonoperating income (expense) | -285 | -32,797 | -1,250* | - |
| Interest expense, nonoperating | 776 | 4,304 | 10,656* | - |
| Total other (expense) income | -1,061 | -37,101 | -11,906* | - |
| Preferred stock dividends, income statement impact | - | - | - | 12,689 |
| Income tax expense (benefit) | 0 | 0 | 0* | - |
| Net (gain) income | 97,677 | -239,852 | -379,751 | 271,472 |
| Less income allocated to convertible preferred stocks | 13,006 | 13,006 | 12,882* | - |
| Undistributed earnings (gain) allocated to participating securities, basic | 40,884 | - | -207,730* | 123,323 |
| Net income (gain) applicable to common stockholders | 43,787 | -252,858 | -184,903 | 135,460 |
| Basic EPS | 0.01 | -0.03 | -0.025 | 0.02 |
| Diluted EPS | 0.01 | -0.03 | -0.013 | 0.02 |
| Basic Average Shares | 7,415,329 | 7,415,329 | 7,415,329 | 7,415,329 |
| Diluted Average Shares | 14,423,729 | 7,415,329 | 14,252,202* | 14,166,217 |
ESCALON MEDICAL CORP (ESMC)
ESCALON MEDICAL CORP (ESMC)